Please review the following within 250 words:

In the early months of this year, the Arizona Senate passed SB 1570, which indicates steps toward legalizing the therapeutic use of psilocybin within licensed clinical facilities. The bill primarily specifies the creation of an advisory board, the training and licensure requirements, and the establishment of the Psilocybin Control and Regulation Fund managed by the Arizona Department of Health Services . The fund houses grant monies allocated to researching the use of psilocybin in clinical settings to treat mental health and other debilitating conditions. With the main objectives being the allocation of research funding, regulation of legal uses, and the establishment of the advisory board, SB 1570 lays the groundwork for safe implementation within integrated clinical care settings in Arizona. Analysis Resources Available SB 1570 indicates specific professionals authorized to administer the treatment with psilocybin. Those professionals include medical doctors, nurse practitioners, physician assistants and naturopaths . In order to implement psilocybin-assisted therapy into an integrated care setting, the staff administering would need the previous credentials, and would have to have completed the 132 hours of training specified in the bill (Arizona Legislature, n.d.). This represents one of the main elements that pertain to the clinical aspects of integrated care. Clinical treatments would be provided either orally, intravenously, or intramuscularly (Institute for Integrative Therapies, n.d.), therefore no special equipment or technology is required. From a management perspective, billing procedures, procuring the substance, and having staff who are well-versed and adequately trained in administering psychedelic treatments are key components. There is a clinic in Saint Paul, Minnesota which administers treatment with a psychedelic-like substance called ketamine (Institute for Integrative Therapies, n.d.). This clinic is integrated in the sense that they have many providers with varying credentials within the clinic setting (social workers, physicians, psychologists, licensed and drug counselors, doulas, etc). They provide treatment for many different conditions as well, including depression, anxiety, attachment disorders, drug/alcohol abuse, trauma, PTSD, etc (Institute for Integrative Therapies, n.d.). There are numerous ketamine clinics like this located in Arizona and around the country with similar elements of integration. SB 1570 does not indicate whether insurance providers will ultimately be responsible for covering psilocybin-assisted treatments (Arizona Legislature, n.d.). However, with ketamine- assisted treatments, typically a portion of the treatment protocol is covered by health insurance, including initial intake appointments, diagnostic visits, as well as psycho-therapy sessions which take place before and after the ingestion/injection of the mind-altering substance (Institute for Integrative Therapies, n.d.). Regarding procuring the substance, SB 1570 specifies that the owner of the licensed facility must demonstrate that the psilocybin product is from a manufacturer, distributor, dispenser, importer or exporter that also has a license issued according to the controlled substances act. Implementation SB 1570 outlines the establishment of an advisory board composed of diverse professionals with a vested interest in psilocybin regulation, including veterans, psychologists, naturopathic practitioners, law enforcement officials, lawyers, university researchers, and a